本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

26.72
-0.0500-0.19%
盘后26.720.00000.00%16:05 EDT
成交量:37.34万
成交额:995.19万
市值:19.50亿
市盈率:-113.39
高:27.00
开:26.66
低:25.97
收:26.77
数据加载中...
2023/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/31

重要事件披露

Form 8-K - Current report
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/18

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/25

重要事件披露

Form 8-K - Current report
2023/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/07

重要事件披露

Form 8-K - Current report
2023/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/02

重要事件披露

8-K - Current report
2023/03/13

重要事件披露

8-K - Current report
2023/03/02

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/28

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/11/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]